Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

New Data: Spiolto® Respimat® significantly improves exercise capacity in people ...


- 5 Septembre 2016 modifié le 1 Janvier 1970


  • Tiotropium+olodaterol Respimat® with exercise training and behaviour modification significantly increased exercise capacity compared to placebo1,2
  • PHYSACTO® trial data also showed improvements in shortness of breath associated with physical activity for people taking tiotropium+olodaterol Respimat® compared to placebo1
  • Even in early chronic obstructive pulmonary disease (COPD) stages, decreasing activity is a strong predictor of disease worsening and increases the risk of disability and death3,4

(http://me-newswire.net//news/18585/en...



ACTUALITES | INTERNATIONAL | TCHAD | POLITIQUE | CULTURE | EXCLUSIF | Revue de Presse | English News | 中國